Pediatric Intensive Care: Immunomodulation With Activated Protein C ex vivo

Objective: Sepsis is major cause of morbidity and mortality in the Pediatric Intensive Care Unit (PICU). PICU patients may develop transient immune deficiency during sepsis. Activated Protein C (APC) has significant anti-inflammatory and cytoprotective effects. Clinical trials of APC in adult sepsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliwan, Hassan O., Watson, William R. G., Regan, Irene, Philbin, Brian, O'Hare, Fiona M., Strickland, Tammy, O'Neill, Amanda, O'Rourke, Michelle, Blanco, Alfonso, Healy, Martina, Nolan, Beatrice, Smith, Owen, Molloy, Eleanor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776988/
https://www.ncbi.nlm.nih.gov/pubmed/31612119
http://dx.doi.org/10.3389/fped.2019.00386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776988/
https://www.ncbi.nlm.nih.gov/pubmed/31612119
http://dx.doi.org/10.3389/fped.2019.00386

Ejemplares similares